VulnerabilityAnalyzed
CVE-2026-41360
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows.
MEDIUM 5.4EPSS 0.09%
Does this matter?
Lower severity and a low EPSS score (0.09%). Track it; it rarely justifies an emergency change on its own.
Description
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
- CVSS 4.0
- 5.4 MEDIUMCVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.09% probability · 1th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-367
- Affected
- openclaw/openclaw
- Source
- disclosure@vulncheck.com
References
- https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeffPatch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcjVendor Advisory
- https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-dlx-local-script-bindingThird Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.